Home 2018-06-15T14:33:48+00:00
AffloVest Mobile HFCWO Airway Clearance Therapy
Is it more than COPD?
50 AffloVests in 50 States
Image is not available
previous arrow
next arrow

“It is hard to believe there is actually a company with people like you who really care, listen and then follow through.”

Elisa-Baltimore MD

Fully mobile during use HFCWO Airway Clearance Therapy

No hoses, No compressor

Anatomically targeted therapy

Full range of sizes

Lung function improvement shown in clinician data


The AffloVest is battery operated and uses Direct Dynamic Oscillation™ technology to closely mimic hand CPT to help mobilize and clear secretions, for full freedom of mobility during treatment. The AffloVest features 8 built-in oscillating modules that, for the full range of sizes offered, are anatomically placed to target the lobes of the lung for targeted customized treatment plans using a digital controller.

The AffloVest pioneered mechanical oscillation airway clearance therapy for patients with severe respiratory diseases such as bronchiectasis, cystic fibrosis, and other neuromuscular diseases.*

Lung Function Improvement Demonstrated in Clinician Data

The proof is in the data. Multiple clinician papers confirm results we’ve seen before – improved patient lung function with AffloVest® by International Biophysics. Average FVC, FEV1, and FEF 25-75% scores increased 15.22%, 17.41%, and 11.21% respectively.

Is it more than COPD? Is Airway Clearance Therapy for you?

An estimated 5 million COPD patients may have BRONCHIECTASIS. Ask your doctor about screening for bronchiectasis and whether Mobile Airway Clearance Therapy is for you.  Learn more here and get your free resource kit

Video Gallery

Featured Video

The Colton Underwood Legacy Foundation and International Biophysics, the manufacturer of the AffloVest Mobile Airway Clearance Therapy vest, have partnered to bring 50 Cystic Fibrosis patients next generation treatment to those who need it most. See the press release here

* AffloVest requires a doctor’s prescription for treatment by High Frequency Chest Wall Oscillation (HFCWO). The AffloVest has received the FDA’s 510k clearance for U.S. market availability, and is approved for Medicare and private health insurance reimbursement under the Healthcare Common Procedure Coding System (HCPCS) code E0483 – High Frequency Chest Wall Oscillation.
** Patients must qualify to meet eligibility requirements.